Navigation Links
Dead Skunk Tests Positive For Rabies
Date:4/4/2008

STURBRIDGE, Mass., April 4, 2008 /PRNewswire-USNewswire/ -- Officials at Old Sturbridge Village report that a dead skunk was found in a cow pen on Thursday. In accordance with procedures, the OSV farm staff notified local animal control and board of health officials. The remains were sent to the Massachusetts state lab for testing. Lab results confirmed that the dead skunk tested positive for rabies.

At this time, it does not appear that any OSV animals are affected. OSV routinely vaccinates its animals against rabies. As a precaution, however, OSV will restrict public contact with its farm animals for 45 days. The village staff has notified public health authorities with jurisdiction over this matter. Old Sturbridge Village remains open for visitation as usual, and all programs and activities will continue as scheduled.
Anyone seeking more information may contact the Village at 508-347-0300.

Contact:

Jim Donahue 508-347-0341; 774-230-3932 cell

Ann Lindblad 508-886-2689 cell


'/>"/>
SOURCE Old Sturbridge Village
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Mach One Corporation Announces Completion of Final Tests Prior to Full Scale Production
2. FASgen Diagnostic Tests Identify Ovarian Cancer Progression and Apoptosis
3. DNA-Based HPV Tests More Accurate Than Pap Smears
4. Spit tests may soon replace many blood tests
5. Heart Risk Can Be Predicted Without Lab Tests
6. Hospital Chain and Hand Picked Union, SEIU, Forced to Cancel Rigged Election After Protests by RNs and Other Employees
7. AGA supports new guidelines favoring tests that prevent colorectal cancer
8. TU Delft tests windmill for seawater desalination
9. Aussie neuroscientist tests addiction drug
10. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
11. Love and Diabetes: dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, ... recognized for adherence to the highest standards of trauma, maternity, cancer and chronic ... center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the American ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... ... Coppin Insurance Agency, an insurance and financial planning firm based in Lee ... is embarking on a charity drive with the goal of providing support and donations ... Bank of Southwest Florida works to provide fresh and nutritious food free of charge ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: